Evidence map›Paper›PMID 33461172›Full record

ArticleAging2021

Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.

Wei Song, Ke Yang, Jianjun Luo, Zhiyong Gao, Yunliang Gao

Open access · greenAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. [Research Progress on the Role and Mechanisms of PYCR1 
in Tumorigenesis and Progression].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Associations BetweenPharmacogenomics and personalized medicine · 2025
    Article
  14. Article
  15. Article
  16. mOncogene · 2024
    Article
  17. Article
  18. RNA NNature reviews. Urology · 2024
    Review
  19. Regulations of mFrontiers of medicine · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wei SongDepartment of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, Hunan Province, China.
Ke YangDepartment of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, Hunan Province, China.
Jianjun LuoDepartment of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, Hunan Province, China.
Zhiyong GaoDepartment of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, Hunan Province, China.
Yunliang GaoDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.
Hunan Normal University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N6-methyladenosine refers to a methylation of adenosine base at the 6

Indexed as

AdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOAnimalsCarcinogenesisCarcinoma, Transitional CellCell Line, TumorCell MovementCell Proliferationdelta-1-Pyrroline-5-Carboxylate ReductaseDisease ProgressionGene Knockdown TechniquesGene Knock-In TechniquesHumansMethylationMiceNeoplasm StagingAdenosineAlpha-Ketoglutarate-Dependent Dioxygenase FTOdelta-1-Pyrroline-5-Carboxylate ReductaseFTO protein, humanN-methyladenosinePyrroline Carboxylate ReductasesRNA, MessengerUbiquitin ThiolesteraseUSP18 protein, humanbladder cancerFTOm6AmethylationN6-methyladenosine

Identifiers

PMID33461172
PMCPMC7906198
OpenAlexW3120709835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.